COVID drug trial for kids halted early

NCT ID NCT05074420

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the drug baricitinib in children aged 1 to 18 who were hospitalized with COVID-19 and needed extra oxygen. The goal was to see if the drug was safe and how it worked in kids. Only 6 children took part before the study was stopped early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONA VIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arnold Palmer Hospital for Children

    Orlando, Florida, 32806, United States

  • CECIP - Centro de Estudos do Interior Paulista

    Jaú, 17201130, Brazil

  • Centro de Pesquisa Sao Lucas

    Campinas, 13034-685, Brazil

  • Children's Hospital of Michigan

    Detroit, Michigan, 48201, United States

  • Complejo Hospitalario de Navarra

    Pamplona, 31009, Spain

  • Hospital Infantil de Mexico Federico Gomez

    Mexico City, 06720, Mexico

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Hospital Universitario de Araba (HUA)- Hospital Txagorritxu

    Vitoria-Gasteiz, 01009, Spain

  • Hospital de Clinicas de Porto Alegre

    Porto Alegre, 90410000, Brazil

  • Instituto Nacional de Pediatria

    Mexico City, 04530, Mexico

  • Instituto de Pesquisa clinica de Campinas

    Campinas, 13060-080, Brazil

  • Pesquisare Saude

    Santo André, 09080-110, Brazil

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.